Ultrasensitive Ebola Virus Antigen Sensing via 3D Nanoantenna Arrays

Faheng Zang, Zhijuan Su, Liangcheng Zhou, Krishnamurthy Konduru, Gerardo Kaplan, Stephen Y. Chou

Research output: Contribution to journalArticle

Abstract

Sensitive detection of pathogens is crucial for early disease diagnosis and quarantine, which is of tremendous need in controlling severe and fatal illness epidemics such as of Ebola virus (EBOV) disease. Serology assays can detect EBOV-specific antigens and antibodies cost-effectively without sophisticated equipment; however, they are less sensitive than reverse transcriptase polymerase chain reaction (RT-PCR) tests. Herein, a 3D plasmonic nanoantenna assay sensor is developed as an on-chip immunoassay platform for ultrasensitive detection of Ebola virus (EBOV) antigens. The EBOV sensor exhibits substantial fluorescence intensity enhancement in immunoassays compared to flat gold substrate. The nanoantenna-based biosensor successfully detects EBOV soluble glycoprotein (sGP) in human plasma down to 220 fg mL−1, a significant 240 000-fold sensitivity improvement compared to the 53 ng mL−1 EBOV antigen detection limit of the existing rapid EBOV immunoassay. In a mock clinical trial, the sensor detects sGP-spiked human plasma samples at two times the limit of detection with 95.8% sensitivity. The results combined highlight the nanosensor's extraordinary capability of detecting EBOV antigen at ultralow concentration compared to existing immunoassay methods. It is a promising next-generation bioassay platform for early-stage disease diagnosis and pathogen detection for both public health and national security applications.

Original languageEnglish (US)
Article number1902331
JournalAdvanced Materials
Volume31
Issue number30
DOIs
StatePublished - Jul 26 2019

Fingerprint

Antigens
Viruses
Plasma (human)
Glycoproteins
Pathogens
Assays
Sensors
Nanosensors
Nanoantennas
National security
Bioassay
Polymerase chain reaction
RNA-Directed DNA Polymerase
Public health
Biosensors
Antibodies
Gold
Fluorescence
Substrates
Costs

All Science Journal Classification (ASJC) codes

  • Materials Science(all)
  • Mechanics of Materials
  • Mechanical Engineering

Cite this

Zang, Faheng ; Su, Zhijuan ; Zhou, Liangcheng ; Konduru, Krishnamurthy ; Kaplan, Gerardo ; Chou, Stephen Y. / Ultrasensitive Ebola Virus Antigen Sensing via 3D Nanoantenna Arrays. In: Advanced Materials. 2019 ; Vol. 31, No. 30.
@article{00aca3868c0c4927b265adc66bcdd709,
title = "Ultrasensitive Ebola Virus Antigen Sensing via 3D Nanoantenna Arrays",
abstract = "Sensitive detection of pathogens is crucial for early disease diagnosis and quarantine, which is of tremendous need in controlling severe and fatal illness epidemics such as of Ebola virus (EBOV) disease. Serology assays can detect EBOV-specific antigens and antibodies cost-effectively without sophisticated equipment; however, they are less sensitive than reverse transcriptase polymerase chain reaction (RT-PCR) tests. Herein, a 3D plasmonic nanoantenna assay sensor is developed as an on-chip immunoassay platform for ultrasensitive detection of Ebola virus (EBOV) antigens. The EBOV sensor exhibits substantial fluorescence intensity enhancement in immunoassays compared to flat gold substrate. The nanoantenna-based biosensor successfully detects EBOV soluble glycoprotein (sGP) in human plasma down to 220 fg mL−1, a significant 240 000-fold sensitivity improvement compared to the 53 ng mL−1 EBOV antigen detection limit of the existing rapid EBOV immunoassay. In a mock clinical trial, the sensor detects sGP-spiked human plasma samples at two times the limit of detection with 95.8{\%} sensitivity. The results combined highlight the nanosensor's extraordinary capability of detecting EBOV antigen at ultralow concentration compared to existing immunoassay methods. It is a promising next-generation bioassay platform for early-stage disease diagnosis and pathogen detection for both public health and national security applications.",
author = "Faheng Zang and Zhijuan Su and Liangcheng Zhou and Krishnamurthy Konduru and Gerardo Kaplan and Chou, {Stephen Y.}",
year = "2019",
month = "7",
day = "26",
doi = "10.1002/adma.201902331",
language = "English (US)",
volume = "31",
journal = "Advanced Materials",
issn = "0935-9648",
publisher = "Wiley-VCH Verlag",
number = "30",

}

Ultrasensitive Ebola Virus Antigen Sensing via 3D Nanoantenna Arrays. / Zang, Faheng; Su, Zhijuan; Zhou, Liangcheng; Konduru, Krishnamurthy; Kaplan, Gerardo; Chou, Stephen Y.

In: Advanced Materials, Vol. 31, No. 30, 1902331, 26.07.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Ultrasensitive Ebola Virus Antigen Sensing via 3D Nanoantenna Arrays

AU - Zang, Faheng

AU - Su, Zhijuan

AU - Zhou, Liangcheng

AU - Konduru, Krishnamurthy

AU - Kaplan, Gerardo

AU - Chou, Stephen Y.

PY - 2019/7/26

Y1 - 2019/7/26

N2 - Sensitive detection of pathogens is crucial for early disease diagnosis and quarantine, which is of tremendous need in controlling severe and fatal illness epidemics such as of Ebola virus (EBOV) disease. Serology assays can detect EBOV-specific antigens and antibodies cost-effectively without sophisticated equipment; however, they are less sensitive than reverse transcriptase polymerase chain reaction (RT-PCR) tests. Herein, a 3D plasmonic nanoantenna assay sensor is developed as an on-chip immunoassay platform for ultrasensitive detection of Ebola virus (EBOV) antigens. The EBOV sensor exhibits substantial fluorescence intensity enhancement in immunoassays compared to flat gold substrate. The nanoantenna-based biosensor successfully detects EBOV soluble glycoprotein (sGP) in human plasma down to 220 fg mL−1, a significant 240 000-fold sensitivity improvement compared to the 53 ng mL−1 EBOV antigen detection limit of the existing rapid EBOV immunoassay. In a mock clinical trial, the sensor detects sGP-spiked human plasma samples at two times the limit of detection with 95.8% sensitivity. The results combined highlight the nanosensor's extraordinary capability of detecting EBOV antigen at ultralow concentration compared to existing immunoassay methods. It is a promising next-generation bioassay platform for early-stage disease diagnosis and pathogen detection for both public health and national security applications.

AB - Sensitive detection of pathogens is crucial for early disease diagnosis and quarantine, which is of tremendous need in controlling severe and fatal illness epidemics such as of Ebola virus (EBOV) disease. Serology assays can detect EBOV-specific antigens and antibodies cost-effectively without sophisticated equipment; however, they are less sensitive than reverse transcriptase polymerase chain reaction (RT-PCR) tests. Herein, a 3D plasmonic nanoantenna assay sensor is developed as an on-chip immunoassay platform for ultrasensitive detection of Ebola virus (EBOV) antigens. The EBOV sensor exhibits substantial fluorescence intensity enhancement in immunoassays compared to flat gold substrate. The nanoantenna-based biosensor successfully detects EBOV soluble glycoprotein (sGP) in human plasma down to 220 fg mL−1, a significant 240 000-fold sensitivity improvement compared to the 53 ng mL−1 EBOV antigen detection limit of the existing rapid EBOV immunoassay. In a mock clinical trial, the sensor detects sGP-spiked human plasma samples at two times the limit of detection with 95.8% sensitivity. The results combined highlight the nanosensor's extraordinary capability of detecting EBOV antigen at ultralow concentration compared to existing immunoassay methods. It is a promising next-generation bioassay platform for early-stage disease diagnosis and pathogen detection for both public health and national security applications.

UR - http://www.scopus.com/inward/record.url?scp=85067338720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067338720&partnerID=8YFLogxK

U2 - 10.1002/adma.201902331

DO - 10.1002/adma.201902331

M3 - Article

VL - 31

JO - Advanced Materials

JF - Advanced Materials

SN - 0935-9648

IS - 30

M1 - 1902331

ER -